CG Oncology, Inc. Common stock
USD54.42
-1.11 (-2.00%)
CEO
Arthur Kuan
IPO Date
2024-01-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$55.34
Prev. Close
$55.53
Day Low
$54.09
Day High
$56.98
52W Low
$23.65
52W High
$75.50
Market Cap
$4.80B
Volume
0.96M
| $73.01 |
| 20 Apr 2026 | Mulay James | director | M-Exempt | Disposed | 15,600 | $36.63 |
| 16 Apr 2026 | Bellete Ambaw | President and COO | A-Award | Acquired | 107,508 | $67.68 |
| 16 Apr 2026 | Kasturi Vijay | Chief Medical Officer | A-Award | Acquired | 79,216 | $67.68 |
| 16 Apr 2026 | Patterson Joshua F. | See Remarks | A-Award | Acquired | 45,266 | $67.68 |
| 16 Apr 2026 | DETORE JAMES M. | Chief Financial Officer | A-Award | Acquired | 90,574 | $67.68 |
| 16 Apr 2026 | Kuan Arthur | director, officer: Chief Executive Officer | A-Award | Acquired | 271,600 | $67.68 |
| 17 Mar 2026 | Mulay James | director | S-Sale | Disposed | 1,310 | $63.50 |
| 17 Mar 2026 | Mulay James | director | M-Exempt | Acquired | 1,310 | $12.59 |